DBVT - DBV Technologies S.A.
| Previous close | 3.8400 |
| Open | 4.0000 |
| Bid | 4.2100 x 1000 |
| Ask | 6.5000 x 1000 |
| Day's range | 3.9800 - 4.3000 |
| 52-week range | 2.0200 - 13.4900 |
| Volume | 402,729 |
| Avg. volume | 616,012 |
| Market cap | 484.492M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.2655 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.18 |
- Simply Wall St.
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts
The analysts covering DBV Technologies S.A. (EPA:DBV) delivered a dose of negativity to shareholders today, by making...
- Simply Wall St.
Did You Manage To Avoid DBV Technologies's (EPA:DBV) Devastating 77% Share Price Drop?
While it may not be enough for some shareholders, we think it is good to see the DBV Technologies S.A. (EPA:DBV) share...
- Zacks
DBV Technologies is in Overbought Territory: What???s Next?
DBV Technologies has moved higher as of late, but there could definitely be trouble on the horizon for this company.
- Simply Wall St.
Does Market Volatility Impact DBV Technologies S.A.'s (EPA:DBV) Share Price?
Anyone researching DBV Technologies S.A. (EPA:DBV) might want to consider the historical volatility of the share...
- Simply Wall St.
If You Had Bought DBV Technologies (EPA:DBV) Stock Three Years Ago, You'd Be Sitting On A 71% Loss, Today
DBV Technologies S.A. (EPA:DBV) shareholders should be happy to see the share price up 18% in the last month. But that...
- Motley Fool
Here's Why Aimmune Therapeutics Fell 7% Today
The Institute for Clinical and Economic Review questions the short-term risks of the biotech's drug.
- Zacks
DBV Technologies S.A. (DBVT) Moves to Buy: Rationale Behind the Upgrade
DBV Technologies S.A. (DBVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- Zacks
DBV Technologies S.A. (DBVT) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in DBV Technologies S.A. (DBVT).
